Riskpilot← Back to searchSign inGet full accessCelluxtreme AB
ABActiveOrg 5592911993StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20205 employees
Revenue 2025
SEK 1,1M
+24% vs 2024
EBITDA margin
34.7%
+14% vs 2024
Equity ratio
4.0%
Financial strength
Net profit 2025
SEK 94K
-18% vs 2024
| Revenue | SEK 1,1M | +24% |
| EBITDA | SEK 372K | +14% |
| Net profit | SEK 94K | -18% |
| Total assets | SEK 7M | +41% |
| Equity | SEK 278K | +51% |
| Employees | 5 | — |
Legal name
Celluxtreme AB
Org number
5592911993
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16 december 2020
Share capital
SEK 27 175
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Naturvetenskaplig och Teknisk F&U Bolaget skall utveckla och framställa avancerade material baserat på biobaserade råvaror och därmed förenlig verksamhet.
Address
Stockholm
Email
daniel@celluxtreme.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 118 | 323 | 440 | 868 | 1 075 |
| Staff expenses | — | −520 | −1 345 | −2 354 | −3 119 |
| EBITDA | 32 | 20 | 23 | 327 | 372 |
| Depreciation & amort. | −0 | — | — | −68 | −139 |
| EBIT | 32 | 20 | 23 | 259 | 234 |
| Net financials | — | 0 | −21 | −64 | −73 |
| Profit before tax | 23 | 20 | 12 | 145 | 119 |
| Tax | −6 | −4 | −3 | −31 | −26 |
| Net profit | 17 | 16 | 9 | 115 | 94 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 193 | 1 547 | 2 870 | 4 931 | 6 968 |
| Equity | 42 | 58 | 69 | 184 | 278 |
| Long-term debt | 0 | — | 1 281 | 669 | 113 |
| Short-term debt | 141 | 1 480 | 1 520 | 4 030 | 6 487 |
| Total debt | 141 | 1 480 | 2 801 | 4 698 | 6 600 |
EBITDA margin
34.7%
This company
15.8%
Market median
+120% vs market
20212025
Equity ratio
4.0%
This company
38.2%
Market median
-90% vs market
20212025
Return on equity
33.8%
This company
18.4%
Market median
+84% vs market
20212025
Net profit margin
8.7%
This company
8.1%
Market median
+7% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
24.09×
This company
0.62×
Market median
-3785% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AK Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
EK Chief Auditor | Chief Auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Celluxtreme AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Magnus Vikström | Chief Executive Officer | 0 companies |
| Anna Kristina Wiberg | Chief Executive Officer | 0 companies |
| Emma Karin Westholm | Chief Auditor | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lars Daniel Söderberg | Board of Directors | 0 companies |
| Karl Mikael Olof Håkansson | Board of Directors | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Erik Magnus Rehn | Chairman | 0 companies |